In-bong Song is currently a Ph.D. candidate at the College of Veterinary Medicine, Jeonbuk National University. He is also a Researcher at the Plastic Materials Research Institute of Osstem Implant, where he is actively involved in the evaluation and development of biomaterials for aesthetic and reconstructive applications. His work primarily focuses on conducting and overseeing in vitro cellular assays and in vivo animal studies to assess biocompatibility, foreign body response, and tissue integration of implantable materials. He has accumulated extensive experience in preclinical research, including the design and analysis of studies related to fibrosis, inflammation, and biomaterial surface modification. His academic training in veterinary medicine provides a strong foundation for translational research using animal models, particularly in the field of implantable medical devices. Through his combined academic and industrial experience, he aims to contribute to the advancement of safer and more effective biomaterials for clinical use.
In-bong Song is currently a Ph.D. candidate at the College of Veterinary Medicine, Jeonbuk National University. He is also a Researcher at the Plastic Materials Research Institute of Osstem Implant, where he is actively involved in the evaluation and development of biomaterials for aesthetic and reconstructive applications. His work primarily focuses on conducting and overseeing in vitro cellular assays and in vivo animal studies to assess biocompatibility, foreign body response, and tissue integration of implantable materials. He has accumulated extensive experience in preclinical research, including the design and analysis of studies related to fibrosis, inflammation, and biomaterial surface modification. His academic training in veterinary medicine provides a strong foundation for translational research using animal models, particularly in the field of implantable medical devices. Through his combined academic and industrial experience, he aims to contribute to the advancement of safer and more effective biomaterials for clinical use.